Similar Articles
Propranolol and cancer
Zehra Pınar Cengiz, Oytun Erbaş
DOI: 10.5606/fng.transplantasyon.2018.008
Natural health products that inhibit tumoral angiogenesis
Emin Taşkıran, Harun Akar, Oytun Erbaş
DOI: 10.5606/fng.transplantasyon.2017.001
Cancer immunotherapy
Ahmet Anıl Özlük, Merve Güner Oytun, Damla Günenç
DOI: 10.5606/fng.transplantasyon.2017.004
The role of angiogenesis in physiological and pathological conditions
Rasim Hamutoğlu, Ozan Önder
DOI: 10.5606/fng.transplantasyon.2017.010
Non-small cell lung cancer and its treatment
Havvanur Akbulut, Semanur İncedayı, Özüm Atasoy
DOI: 10.5606/dsufnjt.2019.004
Urinary tumor markers for diagnosis of prostate cancer
Mine Ün, Mustafa Sel
DOI: 10.5606/dsufnjt.2019.010
Repigmentation observed in hair due to cancer immunotherapy
Esra Nur Arslan, Oytun Erbaş
DOI: 10.5606/fng.transplantasyon.2018.004
PD-1, PD-L1 mechanism and cancer treatment
Aslı Babayakalı, Oytun Erbaş
DOI: 10.5606/dsufnjt.2021.019
Tumor markers and clinical use
Burak Akverdi, Oytun Erbaş
DOI: 10.5606/dsufnjt.2021.023
Alkaliptosis: A new strategy for cancer therapy
Beyza Emine Kılınç, Oytun Erbaş
DOI: 10.5606/dsufnjt.2021.024
Bone marrow transplantation use on treatment solid tumors
İlayda Üzümcü, Oytun Erbaş
DOI: 10.5606/dsufnjt.2021.026
Cancer cells and alpha-ketoglutarate
Yalda Sadeghian, İlayda Üzümcü, Oytun Erbaş
DOI: 10.5606/dsufnjt.2021.029